NO983508L - Antiglukortikoidmedikament - Google Patents

Antiglukortikoidmedikament

Info

Publication number
NO983508L
NO983508L NO983508A NO983508A NO983508L NO 983508 L NO983508 L NO 983508L NO 983508 A NO983508 A NO 983508A NO 983508 A NO983508 A NO 983508A NO 983508 L NO983508 L NO 983508L
Authority
NO
Norway
Prior art keywords
aliphatic
pheromones
drugs
mammalian cells
carbon atoms
Prior art date
Application number
NO983508A
Other languages
English (en)
Norwegian (no)
Other versions
NO983508D0 (no
Inventor
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Original Assignee
Sergei Dmitrievich Burlakov
Dmitry Dmitrievich Genkin
Kirill Gennadievich Surkov
Viktor Veniaminovich Tets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sergei Dmitrievich Burlakov, Dmitry Dmitrievich Genkin, Kirill Gennadievich Surkov, Viktor Veniaminovich Tets filed Critical Sergei Dmitrievich Burlakov
Publication of NO983508D0 publication Critical patent/NO983508D0/no
Publication of NO983508L publication Critical patent/NO983508L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO983508A 1996-01-31 1998-07-30 Antiglukortikoidmedikament NO983508L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU96101194/14A RU2125446C1 (ru) 1996-01-31 1996-01-31 Антиглюкокортикоидное лекарственное средство
PCT/RU1996/000028 WO1997027845A1 (fr) 1996-01-31 1996-02-01 Medicament a base d'anti-glucocorticoide

Publications (2)

Publication Number Publication Date
NO983508D0 NO983508D0 (no) 1998-07-30
NO983508L true NO983508L (no) 1998-07-30

Family

ID=20175968

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983508A NO983508L (no) 1996-01-31 1998-07-30 Antiglukortikoidmedikament

Country Status (24)

Country Link
US (1) US5965623A (et)
EP (1) EP0896819A4 (et)
JP (1) JPH11504946A (et)
KR (1) KR100347862B1 (et)
CN (1) CN1213964A (et)
AU (1) AU710479B2 (et)
BG (1) BG102709A (et)
BR (1) BR9612470A (et)
CA (1) CA2244985A1 (et)
CZ (1) CZ160598A3 (et)
EE (1) EE9800209A (et)
GE (1) GEP20001955B (et)
HU (1) HUP9900504A2 (et)
LT (1) LT4441B (et)
LV (1) LV12177B (et)
MD (1) MD1430B1 (et)
MX (1) MX9806182A (et)
NO (1) NO983508L (et)
PL (1) PL187564B1 (et)
RU (1) RU2125446C1 (et)
SI (1) SI9620053A (et)
SK (1) SK65598A3 (et)
UA (1) UA48212C2 (et)
WO (1) WO1997027845A1 (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1929401A (en) * 1999-12-01 2001-06-12 Alydar Pharmaceuticals Ltd. Method for screening non-peptide, non-steroid inverterbrate pheromones, compositions containing the same and use of the compositions to treat diseases, conditions, and symptoms thereof
US6548706B2 (en) * 1999-12-23 2003-04-15 Aerojet Fine Chemicals Llc Preparation of 2S,3S-N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl) -p-nitrobenzenesulfonylamide hydrochloride and other derivatives of 2-hydroxy-1,3-diamines
US6806293B1 (en) 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2002072809A1 (en) * 2001-03-12 2002-09-19 Alydar Pharmaceuticals, Inc. Screening non-peptide, non-steroid invertebrate pheromone compounds for mitogen-activated protein kinase modulating activity
US20040018959A1 (en) * 2002-05-02 2004-01-29 Randall S. Hickle System and methods of lipid removal from the body
US6752649B2 (en) * 2002-11-07 2004-06-22 Xentris, Llc Illuminated indicia power supply apparatus and method of manufacture
DE10335845B4 (de) * 2003-05-09 2006-08-31 Müller, Martina, Dr.med. Pheromone als Antikrebsmittel
US20110195501A1 (en) * 2008-08-06 2011-08-11 Pangu Gautam D Ultrasonically induced release from polymer vesicles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US161926A (en) 1875-04-13 Improvement in ink-wells
US2900756A (en) * 1958-12-09 1959-08-25 Jacobson Martin Attractants for the gypsy moth
EP0149847A3 (en) * 1983-12-26 1989-11-08 Eisai Co., Ltd. Therapeutic and preventive agent containing dolichol
JPH0759504B2 (ja) * 1986-01-23 1995-06-28 エーザイ株式会社 ポリプレニルアルコ−ル含有注射剤
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4740627A (en) * 1987-05-21 1988-04-26 Phillips Petroleum Company Synthesis of E,Z-11-tetradecen-1-al
CA1331137C (en) 1988-02-29 1994-08-02 Pfizer, Inc. Transdermal flux enhancing compositions
US5190978A (en) * 1989-09-29 1993-03-02 Dai-Ichi Kogyo Seiyaku Co. Ltd. Carcinostatic compositions and methods

Also Published As

Publication number Publication date
MX9806182A (es) 1998-10-31
KR19990076946A (ko) 1999-10-25
EP0896819A4 (en) 2001-11-07
CN1213964A (zh) 1999-04-14
AU4636396A (en) 1997-08-22
CZ160598A3 (cs) 1998-08-12
BR9612470A (pt) 1999-07-13
LT4441B (lt) 1999-01-25
PL187564B1 (pl) 2004-08-31
CA2244985A1 (en) 1997-08-07
RU2125446C1 (ru) 1999-01-27
JPH11504946A (ja) 1999-05-11
MD1430B1 (ro) 2000-03-31
AU710479B2 (en) 1999-09-23
NO983508D0 (no) 1998-07-30
UA48212C2 (uk) 2002-08-15
GEP20001955B (en) 2000-03-05
EP0896819A1 (en) 1999-02-17
LV12177B (lv) 1999-06-20
KR100347862B1 (ko) 2003-01-24
EE9800209A (et) 1998-12-15
PL322596A1 (en) 1998-02-02
SK65598A3 (en) 1998-09-09
WO1997027845A1 (fr) 1997-08-07
LV12177A (lv) 1998-12-20
LT98054A (en) 1998-10-26
US5965623A (en) 1999-10-12
BG102709A (en) 1999-06-30
HUP9900504A2 (en) 1999-09-28
SI9620053A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
Bodnaryk Potent effect of jasmonates on indole glucosinolates in oilseed rape and mustard
Briggs et al. Phototropic auxin redistribution in corn coleoptiles
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
LV12766A (lv) Composition of l-dopa esters
AU550391B2 (en) Derivatives of c-076 compounds
DE68913476D1 (de) Kosmetisches Präparat.
NO983508L (no) Antiglukortikoidmedikament
Ross et al. Concentrations of gibberellin in chilled hazel seeds
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
Yanighara et al. Rapid analysis of small samples containing forskolin using monoclonal antibodies
Cohen et al. Measurement of inflammatory mediators produced by human keratinocytes in vitro: a predictive assessment of cutaneous irritation
CO4980849A1 (es) Composiciones farmaceuticas -2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona(la mivudina), y su uso en terapia medica
DE59608201D1 (de) Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel
McIsaac et al. New metabolites of serotonin in carcinoid urine
Cleland Auxin-induced methylation in maize
Driedger et al. Non‐phorbol mouse skin tumor promoters do not mimic phorbol myristate acetate in its effects on chick embryo fibroblasts
Marom et al. Prostaglandin-generating factor of anaphylaxis induces mucous glycoprotein release and the formation of lipoxygenase products of arachidonate from human airways
Victor et al. Mechanical inhibition of hypocotyl elongation induces radial enlargement: implications for cytokinin action
Rouillier et al. Influence of a dominant follicle atresia and estradiol release by ovarian follicles during superovulation in cattle
MANDA et al. GENETIC AND PHYSIOLOGICAL CONTROL OF ESTERASES IN EXPERIMENTAL SMALL ANIMALS IV. SEX HORMONE-DEPENDENT ESTERASES IN MOUSE AND RAT KIDNEYS
KR830006251A (ko) 2-클로로-4-트리플루오로메틸-티아졸 카보티오산 및 그의 유도체
GB931115A (en) Pharmaceutical preparations containing sitosterols
Hope et al. Metabolism of 3-indoleacetic acid in tobacco exposed to the air pollutant peroxyacetyl nitrate
DE59801586D1 (de) Zur topischen applikation bestimmte diclofenac-lösung
KR920017638A (ko) 농약 중독 예방용 피부 보호제 조성물